View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Announcing the DPharm 2017 Program

  • July 20, 2017

  • Dear DPharm Community,

    After several months of research, including three advisory board meetings, numerous one-on-one interviews and feedback from 2016 attendees, I am pleased to announce that the 7th annual DPharm agenda is published and registration is open. When organizing an event that presents the latest examples of innovative thinking in clinical trials, our research has to carefully find the right balance between new ideas/ projects/ accomplishments, the growth of previously presented ideas and new technologies.

    Next Generation Ideas
    A vital part of DPharm is looking at next generation ideas. For 2017 these include an industry insider from Pfizer on how blockchain can speed up the drug development process and change the business model of clinical development. Other examples are the impact of artificial intelligence in clinical research, digital therapeutics for enhanced clinical outcomes, lessons from the hurdles of the microbiome for clinical trials, and next steps for digital biomarkers.

    Benchmarking Ideas and Progress
    This year, we are including a panel with R&D leaders on what they are trying to disrupt and the status of their ambitious projects, to help you benchmark how the industry is progressing. We also cover examples on how two different pharma companies bootstrap their innovation to accelerate the adoption of new ideas and technologies.

    New Speakers
    We are excited to welcome many new speakers, including Dr Adrian Hernandez, the co-investigator of the ADAPTABLE Study from PCORnet; Barry Crist from Eli Lilly, who will lead an optional workshop on Co-Designing; Dana Lewis, the patient who is democratizing R&D to reduce the burden of type 1 diabetes; Dr John-PeterBradford, another patient disrupter, who is making real-world inclusion criteria a reality; MIT Professor Dina Katabi on wireless remote monitoring; and Esther Dyson, one of the most creative innovative futurists in healthcare, to name a few.

    Wide Range of Technologies
    DPharm now includes more track choices to allow you to customize what technology and services can help you. DPharm Idol is already filling up with exciting possibilities for clinical researchers, and we have an outstanding group of judges, who will oversee a helpful Q&A.

    Pre-Conference Events on September 6

    The event’s networking sessions will be educational, interactive and entertaining. The exhibit hall is not generalized, but focused on innovative solutions and technologies for clinical researchers. You will have the opportunity to meet patients who have experienced a clinical trial, reserve tables for group and one-on-one meetings, and yes, we will have the empathy section with therapy dogs, an art therapy booth and virtual reality demos. Meals, snacks, tea/coffee and chocolates will be provided in the hall.

    Agenda and Registration Open with First Time Offer
    With the first draft of the agenda now published, take advantage of the earliest rates. For the first time, we are offering a guest pass to pharma and biotech companies that would like to invite a member of their team who has not yet attended DPharm. This offer was suggested by advisory board members to help support the spread of innovation within pharma/biotech. Please note this offer expires August 18.

    Please let us know if you have any questions. My team and I are busy preparing to make this the best on-site experience, and we hope you will be able to attend DPharm 2017!

    Valerie Bowling
    Executive Director, DPharm